Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.445
-0.005-1.11%
Volume:641.91K
Turnover:288.37K
Market Cap:267.18M
PE:-18.82
High:0.460
Open:0.460
Low:0.445
Close:0.450
52wk High:0.785
52wk Low:0.340
Shares:600.40M
Float Shares:467.70M
Volume Ratio:0.82
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.024
EPS(LYR):-0.024
ROE:-83.97%
ROA:-32.13%
PB:19.97
PE(LYR):-18.82

Loading ...

Company Profile

Company Name:
DIMERIX LTD
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
425 Smith Street,Fitzroy,Victoria,Australia
Zip Code:
3065
Fax:
61 8 9388 8256
Introduction:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.